About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT07199972

COVID-Related Tinnitus Timeline

COVID-19 is a respiratory disease caused by the coronavirus SARS-CoV-2, for which the first cases were reported in China, by December 2019. Previous studies reported cases of tinnitus following COVID ...

Lead sponsor: Faculdade de Medicina de Valenca•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Faculdade de Medicina de Valenca

Two-hundred and thirty three patients over 18 years old and previously diagnosed with COVID-19 confirmed by either a RT-PCR, antibodies or antigens test were included. Patients were subdivided in three groups: no tinnitus (NT), tinnitus that already existed before COVID-19 (chronic tinnitus, CT) and tinnitus that arose during or after COVID-19 (post-COVID-19 tinnitus, PCT). Data concerning COVID-19 symptoms, drugs prescribed for COVID-19, tinnitus characteristics, comorbidities and other otological symptoms were collected. Tinnitus assessment included pure tone audiograms, the Tinnitus Handicap Inventory (THI), visual-analog scales (VAS) for loudness and distress as well as the hospital anxiety and depression scale (HADS). Patients with CT were additionally asked whether their tinnitus worsened after their COVID-19 infection.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•previous COVID-19 infection

Exclusion Criteria

•\< 18 yo
•not willing to give informed consent

Related studies

ListenFuture-Listening for Their Future: Deaf and Hard-of-Hearing Adolescents

NCT07416292 · Hearing Disorders and Deafness

Preschool Hearing Screening

NCT06058767 · Hearing Loss, Hearing Disorders in Children, and more

RECRUITINGPhase 1/2

A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

NCT07304024 · Central Auditory Processing Disorder, Hearing Impaired (Partially), and more

NIDCD Otolaryngology Clinical Protocol Biospecimen Bank

NCT06303180 · Hearing Loss, Head and Neck Neoplasms, and more

Corona Virus Disease 2019 Cohort Study

NCT06927622 · COVID-19 Pneumonia, COVID-19 Pandemic, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 30, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment233

Start dateFeb 2023

Last updatedSep 30, 2025

Condition

Hearing Disorders COVID-19 Pandemic

Locations shown

OTOSUL, Otorrinolaringologia Sul-Fluminense

Volta Redonda, Rio de Janeiro

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 30, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions